398 related articles for article (PubMed ID: 19026757)
1. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.
Rodrigo GJ; Moral VP; Marcos LG; Castro-Rodriguez JA
Pulm Pharmacol Ther; 2009 Feb; 22(1):9-19. PubMed ID: 19026757
[TBL] [Abstract][Full Text] [Related]
2. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
Cates CJ; Wieland LS; Oleszczuk M; Kew KM
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
[TBL] [Abstract][Full Text] [Related]
3. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 May; (5):CD005535. PubMed ID: 20464739
[TBL] [Abstract][Full Text] [Related]
4. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
[TBL] [Abstract][Full Text] [Related]
5. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.
Walters EH; Gibson PG; Lasserson TJ; Walters JA
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001385. PubMed ID: 17253458
[TBL] [Abstract][Full Text] [Related]
6. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events.
Bateman E; Nelson H; Bousquet J; Kral K; Sutton L; Ortega H; Yancey S
Ann Intern Med; 2008 Jul; 149(1):33-42. PubMed ID: 18523132
[TBL] [Abstract][Full Text] [Related]
8. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 Apr; (4):CD005533. PubMed ID: 20393943
[TBL] [Abstract][Full Text] [Related]
9. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
10. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
12. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.
Ni Chroinin M; Lasserson TJ; Greenstone I; Ducharme FM
Cochrane Database Syst Rev; 2009 Jul; (3):CD007949. PubMed ID: 19588447
[TBL] [Abstract][Full Text] [Related]
13. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ram FS; Cates CJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
[TBL] [Abstract][Full Text] [Related]
14. Long-acting beta-agonists in adult asthma: Evidence that these drugs are safe.
Nelson HS
Prim Care Respir J; 2006 Oct; 15(5):271-7. PubMed ID: 16979380
[TBL] [Abstract][Full Text] [Related]
15. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Jaeschke R; Schmidt S; Ferrer M
Cochrane Database Syst Rev; 2013 Mar; (3):CD006922. PubMed ID: 23543548
[TBL] [Abstract][Full Text] [Related]
16. Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews.
Cates CJ; Oleszczuk M; Stovold E; Wieland LS
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD010005. PubMed ID: 23076961
[TBL] [Abstract][Full Text] [Related]
17. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
18. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ; Jaeschke R
Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
[TBL] [Abstract][Full Text] [Related]
19. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.
Ni Chroinin M; Greenstone I; Lasserson TJ; Ducharme FM
Cochrane Database Syst Rev; 2009 Oct; (4):CD005307. PubMed ID: 19821344
[TBL] [Abstract][Full Text] [Related]
20. Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.
Cates CJ; Schmidt S; Ferrer M; Sayer B; Waterson S
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD006922. PubMed ID: 30521673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
